ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
ONWARD Medical N.V. announced that all proposed resolutions at its 2026 Annual General Meeting of Shareholders were approved. The meeting took place in Amsterdam, and the company focuses on pioneering therapies for spinal cord injuries and movement disabilities. It has received numerous FDA Breakthrough Device Designations and is advancing its ARC Therapy technologies.
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)